关注
Joseph Estabrook
Joseph Estabrook
Computational Biologist, OHSU
在 ohsu.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
An expanded universe of cancer targets
WC Hahn, JS Bader, TP Braun, A Califano, PA Clemons, BJ Druker, ...
Cell 184 (5), 1142-1155, 2021
1742021
Transcriptome alterations in myotonic dystrophy skeletal muscle and heart
ET Wang, D Treacy, K Eichinger, A Struck, J Estabrook, H Olafson, ...
Human molecular genetics 28 (8), 1312-1321, 2019
1252019
An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer
BE Johnson, AL Creason, JM Stommel, JM Keck, S Parmar, CB Betts, ...
Cell Reports Medicine 3 (2), 2022
402022
Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG) n repeat
AEEG Gudde, SJ van Heeringen, AI de Oude, IDG van Kessel, ...
RNA biology 14 (10), 1374-1388, 2017
352017
Heterologous saRNA prime, DNA dual-antigen boost SARS-CoV-2 vaccination elicits robust cellular immunogenicity and cross-variant neutralizing antibodies
A Rice, M Verma, E Voigt, P Battisti, S Beaver, S Reed, K Dinkins, S Mody, ...
Frontiers in Immunology 13, 910136, 2022
92022
PU. 1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia
BM Curtiss, J VanCampen, J Macaraeg, GL Kong, A Taherinasab, ...
Leukemia 36 (7), 1781-1793, 2022
72022
Selective enrichment of plasma cell-free messenger RNA in cancer-associated extracellular vesicles
HJ Kim, MJ Rames, F Goncalves, CW Kirschbaum, B Roskams-Hieter, ...
Communications Biology 6 (1), 885, 2023
52023
Disruption of the MYC superenhancer complex by dual targeting of FLT3 and LSD1 in acute myeloid leukemia
WM Yashar, BM Curtiss, DJ Coleman, J VanCampen, G Kong, ...
Molecular Cancer Research 21 (7), 631-647, 2023
42023
PU. 1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia
BM Smith, J VanCampen, GL Kong, W Yashar, YH Tsang, W Horton, ...
BioRxiv, 2021.08. 24.456354, 2021
42021
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors
TP Braun, J Estabrook, Z Schonrock, BM Curtiss, L Darmusey, ...
Leukemia 37 (2), 478-487, 2023
32023
Oncogenic SETBP1 Mutations Combine with Activating Mutations in CSF3R to Produce a Highly Proliferative, Lethal Leukemia through Aberrant Myc Signaling
SA Carratt, TP Braun, Z Schonrock, BM Smith, DJ Coleman, G Kong, ...
Blood 136, 51-52, 2020
22020
Predicting transcription factor activity using prior biological information
WM Yashar, J Estabrook, HD Holly, J Somers, O Nikolova, Ö Babur, ...
Iscience 27 (3), 2024
12024
The transcriptional and epigenetic reprogramming mediated by chronic IL1β exposure drives self-renewal ability and myeloid priming in TET2 deficient stem and progenitor cells
J McClatchy, R Strogantsev, E Wolfe, J Estabrook, H Lin, ...
Cancer Biol 10 (2022.09), 15.507688, 2022
12022
Interplay between Inflammatory Microenvironment and RUNX1-Mediated Transcriptomic Changes Drives Defective Hematopoiesis in Familial Platelet Disorder
M M Hosseini, T Enright, AS Duvall, A Chitsazan, HY Lin, A Ors, B Davis, ...
Blood 142 (Supplement 1), 945-945, 2023
2023
Predicting transcription factor activity using prior biological information
J Estabrook, WM Yashar, HD Holly, J Somers, O Nikolova, Ö Barbur, ...
bioRxiv, 2022.12. 16.520295, 2022
2022
Chronic IL1β Exposure Enhances Self-Renewal Ability and Myeloid Priming in TET2 Deficient Stem and Progenitor Cells
J McClatchy, R Strongantsev, E Wolfe, J Estabrook, HY Lin, M M Hosseini, ...
Blood 140 (Supplement 1), 8594-8595, 2022
2022
The transcriptional and epigenetic reprogramming associated with chronic IL1β-mediated expansion and myeloid priming in TET2 deficient stem and progenitor cells
J McClatchy, R Strogantsev, E Wolfe, H Lin, M Mohammadhosseini, ...
bioRxiv, 2022.09. 15.507688, 2022
2022
Dual targeting of FLT3 and LSD1 disrupts the MYC super-enhancer complex in acute myeloid leukemia
W Yashar, BM Smith, DJ Coleman, J VanCampen, G Kong, J Macaraeg, ...
bioRxiv, 2022.01. 17.476469, 2022
2022
3024–GERMLINE RUNX1 MUTATIONS-MEDIATED CHANGES COOPERATES WITH INFLAMMATORY MICROENVIRONMENT TO DRIVE DEFECTIVE HEMATOPOIESIS IN FAMILIAL PLATELET DISORDER
M Mohammadhosseini, A Duvall, A Chitsazan, T Enright, A Monteblanco, ...
Experimental Hematology 100, S55, 2021
2021
Combined inhibition of cKIT and Lysine-Specific Demethylase 1 as a therapeutic strategy in acute myeloid leukemia
BM Smith, DJ Coleman, L Maloney, C Coblentz, Z Schonrock, J Estabrook, ...
Cancer Research 81 (13_Supplement), 1133-1133, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–20